Capricor Therapeutics, Inc. (CAPR) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

FibroGen, Inc.

SCYNEXIS, Inc.

Aquestive Therapeutics, Inc.

CytomX Therapeutics, Inc.

Capricor Therapeutics, Inc.

Chimerix, Inc.

Achieve Life Sciences, Inc.

aTyr Pharma, Inc.

Annovis Bio, Inc.

Atossa Therapeutics, Inc.

Anebulo Pharmaceuticals, Inc.

Why is Capricor Therapeutics, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Capricor Therapeutics, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Capricor Therapeutics, Inc.

150.65%

1.12

389.66%

S&P 500

14.9%

0.77

19.29%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

63.43%

EBIT Growth (5y)

-242.55%

EBIT to Interest (avg)

-30.73

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.10

Sales to Capital Employed (avg)

1.22

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

59.98%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

19.82

EV to EBIT

-18.08

EV to EBITDA

-18.46

EV to Capital Employed

-139.92

EV to Sales

140.82

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-97.76%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Dow Theory

No Trend

Mildly Bullish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

NET PROFIT(HY)

Higher at USD -50.48 MM

CASH AND EQV(HY)

Highest at USD 221.37 MM

-18What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at USD -61.04 MM

PRE-TAX PROFIT(Q)

At USD -24.57 MM has Fallen at -40.45%

NET PROFIT(Q)

At USD -24.57 MM has Fallen at -40.45%

RAW MATERIAL COST(Y)

Grown by 101.2% (YoY

Here's what is working for Capricor Therapeutics, Inc.

Cash and Eqv

Highest at USD 221.37 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Here's what is not working for Capricor Therapeutics, Inc.

Pre-Tax Profit

At USD -24.57 MM has Fallen at -40.45%

over average net sales of the previous four periods of USD -17.49 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit

At USD -24.57 MM has Fallen at -40.45%

over average net sales of the previous four periods of USD -17.49 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Cash Flow

Lowest at USD -61.04 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Raw Material Cost

Grown by 101.2% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales